通过人工智能识别的细胞分裂蛋白候选冠状病毒疫苗的临床前疗效

Sunita Gulati1, Andreas Holm Mattsson2, Sophie Schussek2

  • 1Department of Medicine, Division of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

mBio
|October 31, 2023
PubMed
概括

新的淋病疫苗至关重要. 人工智能确定了有前途的候选者,FtsN和NGO0265,通过触发补体依赖免疫反应,显著减少了小鼠的细菌殖民.